{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-090625","form_type":"8-K","ticker":"TNON","cik":"0001560293","company_name":"Tenon Medical, Inc.","filed_at":"2023-11-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.518936+00:00","generated_at":"2026-06-07T21:01:10.180604+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Tenon Medical raises $1.125M net via 10% secured notes and warrants","bullets":["Sold $1.25M in secured notes (10% interest, due Nov 21, 2024) with warrants for 45,000 shares at $1.94.","Net proceeds of $1.125M after investor expenses; notes secured by first-priority lien on all assets.","Warrants exercisable immediately for five years, include cashless exercise and anti-dilution provisions.","Proceeds to be used for working capital and general corporate purposes."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-090625","json":"https://secwatch.observer/filing/0001213900-23-090625.json","markdown":"https://secwatch.observer/filing/0001213900-23-090625.md","text":"https://secwatch.observer/filing/0001213900-23-090625.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1560293/000121390023090625/0001213900-23-090625-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1560293/000121390023090625/ea189166-8k_tenonmed.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T21:01:10.180604+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"25e86c28a7485eda69f0fcc151dc2358df21e128","claim":"Tenon Medical, Inc. entered into Securities Purchase Agreements with certain investors valued at $1,250,000 (effective 2023-11-21).","evidence_excerpt":"On November 21, 2023, Tenon Medical, Inc. (the “Company”) entered into Securities Purchase Agreements (the “Purchase Agreements”) with certain investors (the “Investors”), pursuant to which the Company agreed to sell, issue and deliver to the Investors, in a private placement offering (the “Offering”), a total of $1,250,000 in secured notes (the “Notes”) and warrants (the “Warrants”)","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1560293/000121390023090625/0001213900-23-090625-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain investors"},{"label":"Value","value":"$1,250,000"},{"label":"Effective","value":"2023-11-21"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}